Solid Carcinoma clinical trials at UCSF
2 in progress, 0 open to eligible people
Imaging of Solid Tumors Using 18F-TRX
Sorry, not yet accepting patients
This phase I trial tests the safety and effectiveness of 18F-TRX in detecting tumors (cancer) patients with solid tumors. 18F-TRX is an imaging tracer that is used to visualize tumors using a PET scan. It specifically targets and detects labile (unstable) iron levels within tissues, including tumors. Diagnostic procedures, such as 18F-TRX PET/CT or PET/MRI, may help detect tumors in patients with solid tumors
San Francisco, California
PET [89Zr]DFO-starPEG in Solid Tumors
Sorry, not yet accepting patients
This is a first-in-human, pilot study of the novel PET-imaging radiotracer [89Zr]DFO-starPEG. The study is designed to obtain preliminary data to support future development of this agent as an imaging surrogate to visualize enhanced permeability and retention (EPR)-mediated tracer uptake before administration of EPR-based nanomedicines.
San Francisco, California
Our lead scientists for Solid Carcinoma research studies include Rahul Aggarwal, MD Robert Flavell, MD, PhD.
Last updated: